Geoffrey Wolf is 10% Owner at OPIANT PHARMACEUTICALS, INC. (OPNT). They have made 6 open-market trades across 1 company since 2017, most recently 2018-04-08.
CIK 0001657053
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| OPNT | 124,500 | $2.6M |
Shares reported on the most recent Form 4, priced at the 2018-04-17 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 83% | 33% | 100% |
| Avg Move | -5.3% | +1.5% | -13.4% |
| Scored | 6 | 6 | 6 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| OPNT | SELL | 2017-12-27 | 2018-01-18 | $21.51 | $814K | -5.8% | +11.3% | -9.1% |
| OPNT | SELL | 2017-12-21 | 2018-01-18 | $24.17 | $483K | -5.8% | +11.3% | -9.1% |
| OPNT | SELL | 2017-12-19 | 2018-01-18 | $22.52 | $3.9M | -5.8% | +11.3% | -9.1% |
| OPNT | SELL | 2017-12-19 | 2018-01-18 | $19.69 | $76K | -5.8% | +11.3% | -9.1% |
| OPNT | SELL | 2017-12-13 | 2017-12-21 | $22.67 | $1.6M | +3.5% | -15.2% | -13.5% |
| OPNT | SELL | 2017-12-08 | 2017-12-12 | $30.40 | $78K | -12.5% | -21.2% | -30.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.